Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Market Cap	406.78B
Revenue (ttm)	165.60B
Net Income (ttm)	10.07B
Shares Out	74.34M
EPS (ttm)	135.42
PE Ratio	40.41
Forward PE	30.80
Dividend	104.00 (1.90%)
Ex-Dividend Date	Jun 27, 2025

Volume	113,600
Average Volume	301,325
Open	5,472.00
Previous Close	5,447.00
Day's Range	5,438.00 - 5,491.00
52-Week Range	5,016.00 - 6,350.00
Beta	0.47
RSI	47.57
Earnings Date	May 9, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,615
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.